BTG plc (LON:BTG – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 840 ($10.38) and traded as high as GBX 840 ($10.38). BTG shares last traded at GBX 840 ($10.38), with a volume of 271,742 shares traded.
BTG Price Performance
The company has a market capitalization of £3.26 billion and a P/E ratio of 29.47. The business has a 50-day moving average of GBX 840 and a 200-day moving average of GBX 840.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Further Reading
- Five stocks we like better than BTG
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What is a Stock Market Index and How Do You Use Them?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What is the Shanghai Stock Exchange Composite Index?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
